AstraZeneca's deal with U.S. President Donald Trump to lower drug costs for Americans and shield the drugmaker from import tariffs was the culmination of efforts stretching back to November last year, sources have said. https://www.japantimes.co.jp/business/2025/10/14/companies/astrazeneca-medicine-deal-trump/?utm_medium=Social&utm_source=mastodon #business #companies #astrazeneca #pharmaceuticals #us #donaldtrump #trade #tariffs #republicans

AstraZeneca and Daiichi Sankyo’s drug Datroway has significantly improved survival and delayed the progression of breast cancer in patients with a particularly hard to treat form of the disease, AstraZeneca has said. https://www.japantimes.co.jp/business/2025/10/07/companies/astrazeneca-breast-cancer/?utm_medium=Social&utm_source=mastodon #business #companies #astrazeneca #daiichisankyo #health #cancer #medicine #pharmaceuticals